QSS
AXDX icon

Quantitative Systematic Strategies’s Accelerate Diagnostics AXDX Stock Holding History

Quantitative Systematic Strategies’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,315
Closed -$151K – 404
2018
Q4 		$151K Buy
+1,315
New +$195K 0.03% 568
2016
Q1 		– Sell
-1,395
Closed -$302K – 438
2015
Q4 		$302K Buy
+1,395
New +$255K 0.08% 661

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Quantitative Systematic Strategies's AXDX Position: Q1 2019 in Review

Quantitative Systematic Strategies sold out of Accelerate Diagnostics (AXDX) in Q1 2019, closing a stake of 1,315 shares — an estimated $151K sold.

Quantitative Systematic Strategies first reported a position in AXDX in Q4 2015 and held it in 2 quarters. The position peaked at $302K in Q4 2015. 114 funds tracked by Wall St. Rank hold AXDX as of Q1 2019.

  • Quantitative Systematic Strategies reported no remaining Accelerate Diagnostics position as of Q1 2019 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 1,315 Accelerate Diagnostics shares in Q1 2019, an estimated $151K.
  • Quantitative Systematic Strategies first reported a position in Accelerate Diagnostics in Q4 2015 and held it in 2 quarters.
  • Quantitative Systematic Strategies's Accelerate Diagnostics position peaked at $302K in Q4 2015.
  • 114 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2019, filed 15 Apr 2019.